355 related articles for article (PubMed ID: 35328957)
1. Liver Disease Screening and Hepatitis C Virus Elimination in Taiwan Rural Indigenous Townships: Village-By-Village Screening and Linking to Outreach Hepatology Care.
Tien HM; Cheng TC; Lien HC; Yang KF; Shy CG; Chen YL; Hsu NT; Lu SN; Wang JH
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328957
[TBL] [Abstract][Full Text] [Related]
2. Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study.
Chang TS; Chang KC; Chen WM; Hsu NT; Lee CY; Lin YC; Huang WC; Chiu WN; Hu JH; Huang TJ; Chen MY; Lu SN
BMJ Open; 2021 Jul; 11(7):e046115. PubMed ID: 34233977
[TBL] [Abstract][Full Text] [Related]
3. Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan - A multi-center collaborative care model.
Lo CC; Lei WY; Huang YC; Hwang JJ; Lo CY; Lin CH; Cheng HS; Liao YT; Liang PC; Chiou MJ; Bair MJ; Dai CY; Yu ML
J Microbiol Immunol Infect; 2023 Aug; 56(4):680-687. PubMed ID: 36822945
[TBL] [Abstract][Full Text] [Related]
4. Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships.
Kee KM; Chen WM; Hsu NT; Wang JH; Chao WH; Lin YC; Lu SN
J Formos Med Assoc; 2022 Sep; 121(9):1850-1856. PubMed ID: 35339312
[TBL] [Abstract][Full Text] [Related]
5. Community-Based Screening for Hepatitis B and C Infectivity Using Two Quantitative Antigens to Identify Endemic Townships.
Huang WC; Lin YC; Chen PJ; Hsu NT; Tu CL; Chang TS; Hung CH; Kee KM; Chao WH; Lu SN
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215896
[TBL] [Abstract][Full Text] [Related]
6. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
[TBL] [Abstract][Full Text] [Related]
7. Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan.
Wang CS; Chang TT; Chou P
J Clin Epidemiol; 1998 Sep; 51(9):733-8. PubMed ID: 9731921
[TBL] [Abstract][Full Text] [Related]
8. Liver Health Literacy and Health Status Among Adults With Hepatitis C: Implications for the Nursing Profession as Part of the 2030 Global Elimination Goal.
Lin YC; Chiu WN; Chang TS; Huang TJ; Chen MY
J Nurs Scholarsh; 2020 Mar; 52(2):128-135. PubMed ID: 31750620
[TBL] [Abstract][Full Text] [Related]
9. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants.
Chen CH; Yang PM; Huang GT; Lee HS; Sung JL; Sheu JC
J Formos Med Assoc; 2007 Feb; 106(2):148-55. PubMed ID: 17339159
[TBL] [Abstract][Full Text] [Related]
10. GB virus-C/hepatitis G virus infection in a hepatitis C virus endemic village: prevalence in residents with low educational attainment and frequent recovery in females.
Cheng PN; Chang TT; Yang MH; Hu SC; Young KC; Wu HL; Jen CM; Ko AW; Lu SC
Liver; 2000 Jun; 20(3):222-7. PubMed ID: 10902972
[TBL] [Abstract][Full Text] [Related]
11. Mass screening for hepatitis B and C in Southern Upper Egypt.
Soliman G; Elzalabany MS; Hassanein T; Miller FD
BMC Public Health; 2019 Oct; 19(1):1326. PubMed ID: 31640639
[TBL] [Abstract][Full Text] [Related]
12. Collaborative Referral Model for Hepatitis C Screening and Treatment in a Remote Mountainous Region of Taiwan during the COVID-19 Pandemic.
Tai CM; Bair MJ; Chen TH; Tseng CH; Chen CC; Lam H; Yu ML
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112808
[TBL] [Abstract][Full Text] [Related]
13. Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.
Chen CT; Lu MY; Hsieh MH; Tsai PC; Hsieh TY; Yeh ML; Huang CI; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Huang CF; Huang JF; Dai CY; Chuang WL; Shih YL; Yu ML
World J Gastroenterol; 2022 Jan; 28(2):263-274. PubMed ID: 35110949
[TBL] [Abstract][Full Text] [Related]
14. Viral hepatitis infections in southern Taiwan: a multicenter community-based study.
Yang JF; Lin CI; Huang JF; Dai CY; Lin WY; Ho CK; Hsieh MY; Lee LP; Ho NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML; Chuang WL; Chang WY
Kaohsiung J Med Sci; 2010 Sep; 26(9):461-9. PubMed ID: 20837342
[TBL] [Abstract][Full Text] [Related]
15. Challenges of transferring rural adults with chronic HCV infection for further HCV RNA confirmation and free DAAs treatment: a success story of the interdisciplinary collaboration approach.
Li W; Chang TS; Chang SZ; Chen CH; Chen MY
BMC Infect Dis; 2020 Oct; 20(1):737. PubMed ID: 33028228
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis delta virus and GBV-C infection in two neighboring hepatitis B virus and hepatitis C virus-endemic villages in Taiwan.
Chang CJ; Chiang JC; Lu SN; Wang JH
Chang Gung Med J; 2010; 33(2):137-44. PubMed ID: 20438665
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study.
Kamali I; Barnhart DA; Ndahimana JD; Noor K; Mumporeze J; Nyirahabihirwe F; Gakuru JP; Musafiri T; Urusaro S; Makuza JD; Serumondo J; Rwamuhinda DD; Nkundibiza M; Kateera F; Nshogoza GR; Mubiligi JM
PLoS One; 2021; 16(10):e0257917. PubMed ID: 34634039
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection.
Yeh ML; Huang CF; Huang CI; Holmes JA; Hsieh MH; Tsai YS; Liang PC; Tsai PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Chung RT; Yu ML
J Hepatol; 2020 Jul; 73(1):62-71. PubMed ID: 32061869
[TBL] [Abstract][Full Text] [Related]
19. Dual strategy involving hospital-based study and community-based screening to eliminate hepatitis C in remote areas.
Chen CH; Hsu NT; Chen IC; Chang TS; Cheng S; Cheng SY; Chen HM; Harn MR; Liu CK; Yang MT; Lu SL; Tseng CM; Lu SN
J Formos Med Assoc; 2024 May; 123(5):613-619. PubMed ID: 38195318
[TBL] [Abstract][Full Text] [Related]
20. Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan.
Lu MY; Chen CT; Shih YL; Tsai PC; Hsieh MH; Huang CF; Yeh ML; Huang CI; Wang SC; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Yu ML; Chang WY
Sci Rep; 2021 Apr; 11(1):8554. PubMed ID: 33879825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
